In contrast, USP9X was found to be targeted by recurrent truncating mutations and deletion in gingivo-buccal oral squamous cell carcinoma [34] characteristic of a tumour suppressor gene, and reduced expression has been associated with poorer survival and increased metastatic burden in pancreatic ductal adenocarcinoma patients [35]. This evidence concerns the gene USP9X and oral cavity squamous cell carcinoma.